In T lymphocytes, the role of Akt in regulating Fas/Fas ligand (FasL)-mediated apoptotic signaling and death is not clearly understood. In this study, we observed that inhibition of Akt causes enhanced expression of FasL mRNA and protein and increased death-inducing signaling complex (DISC) formation with Fas-associated death domain (FADD) and procaspase-8 recruitment. Also, caspase-8 was activated at the DISC with accompanying decrease in c-FLIP s expression. FasL neutralizing antibody significantly decreased apoptotic death in the Akt-inhibited T cells. Additionally, Akt inhibition-induced Fas signaling was observed to link to the mitochondrial pathway via Bid cleavage. Further, inhibition of caspase-8 activity effectively blocked the loss of mitochondrial membrane potential and DNA fragmentation, suggesting that DISC formation and subsequent caspase-8 activation are critical initiating events in Akt inhibition-induced apoptotic death in T lymphocytes. These data demonstrate yet another important survival function governed by Akt kinase in T lymphocytes, which involves the regulation of FasL expression and consequent apoptotic signaling.
Introduction
The role of the serine-threonine kinase protein kinase B (PKB/Akt) in T lymphocyte survival is well documented. [1] [2] [3] [4] Akt is activated through the direct binding of phosphatidylinositol (3, 4, 5) -triphosphate (PIP 3 ), a lipid second messenger generated by phosphatidylinositol-3-kinase (PI3K). 5, 6 PIP 3 generated by the action of PI3K binds Akt via the pleckstrin homology (PH) domain of Akt, followed by 3-phosphoinositide-dependent protein kinase 1 (PDK1)-mediated phosphorylation at Thr-308 and Ser-473. 5, 6 Upon activation Akt promotes cell survival by phosphorylating and inactivating a variety of key proapoptotic targets in T lymphocytes. 1 Fas/FasL-mediated activation-induced cell death (AICD) plays a pivotal role in the physiological elimination and turnover of lymphocytic cells. Induction of FasL expression has been implicated in drug-and stress-induced apoptotic death of T lymphocytes. 7 Upon stimulation, Fas undergoes trimerization and recruits the proapoptotic adapter protein Fas-associated death domain (FADD) and pro-caspase-8, also called FADDlike interleukin 1 b-converting enzyme (FLICE), to form a death-inducing signaling complex (DISC). [8] [9] [10] [11] Recruitment of pro-caspase-8 to the DISC leads to its proteolytic activation to caspase-8, followed by initiation of a caspase cascade leading to apoptosis. 11 FLICE inhibitory protein (c-FLIP) is an antiapoptotic cytoplasmic protein that has sequence homology to caspase-8. c-FLIP is unable to undergo cleavage to an active caspase due to substitution of a tyrosine for an active site cysteine, and hence can function as a dominant-negative inhibitor of caspase-8, thereby preventing Fas-induced apoptosis. [12] [13] [14] Alternative splicing yields multiple isoforms of c-FLIP; two commonly occurring isoforms are designated c-FLIP L (long isoform) and c-FLIP s (short isoform). 15, 16 c-FLIP is known to play an antiapoptotic role in a number of cell types and elevated c-FLIP expression renders cells resistant to Fas-induced apoptosis. 17 In fact, the susceptibility of T lymphocytes to Fas-mediated apoptosis correlates with c-FLIP levels, which are elevated during the early stages of activation but are significantly reduced upon re-stimulation when the T cells undergo AICD. 7, 18, 19 The molecular mechanisms involved in the regulation of expression of c-FLIP in T lymphocytes are not completely understood.
Analysis of the Fas-mediated pathway has shown that formation of DISC and subsequent caspase-8 activation can link to the mitochondrial apoptotic pathway through the activation of Bid, a proapoptotic member of the Bcl-2 family. 20, 21 Bid-mediated mitochondrial changes include the opening of the mitochondrial pores regulating permeability transition, decrease in the membrane potential (DC m ) and release of cytochrome C into the cytoplasm, which further complexes with Apaf-1 and activates caspase-9. [22] [23] [24] Eventually, these apoptotic events culminate in the activation of executioner caspases, for example, caspase-3 leading to DNA fragmentation and cell death. 25 Although several antiapoptotic functions of Akt have been identified in T lymphocytes, the potential role of Akt in regulating FasL and c-FLIP expression, and the impact on subsequent apoptotic signaling, has not been examined. The results showed that inhibition of Akt, using either PI3 kinase inhibitor or a selective Akt inhibitor, upregulates FasL gene expression. Moreover, inhibition of Akt resulted in a correspondent decrease in c-FLIP s expression and an increase in caspase-8 activity leading to Fas-mediated apoptosis. Role of FasL-dependent cell death in Akt-inhibited cells was further supported by the observations using FasL antagonistic (neutralizing) antibody and caspase-8 inhibitor, both of which significantly attenuated apoptosis. Taken together, these data demonstrate a critical survival function of Akt in T lymphocytes, that involves downregulation of FasL and control of DISC formation by regulating the expression and/or function of c-FLIP and caspase-8.
Results
To inhibit activation of Akt, T cells were treated with LY-294002 (LY), a known pharmacological inhibitor of PI3 kinase (PI3K), which is the upstream activator of Akt. Although LY has been extensively used to examine the role of PI3K/Akt in several cellular systems, it is also known to inhibit casein kinase 2 (CK2) with potency similar to PI3 kinase. 26 Hence, in order to specifically evaluate the role of Akt kinase, a selective Akt inhibitor (AI-III) was also employed in these studies. AI-III is a 2-modified, 3-deoxy phosphatidylinositol analog with phosphate linkers, which specifically inhibits Akt phosphorylation and activity without affecting any upstream kinases such as PI3K or PDK-1 as well as extracellular signalregulated kinase (ERK). 27, 28 Effect of Akt inhibition on cell viability and apoptotic cell death Both LY and AI-III blocked Akt activation in a dose-dependent manner as measured by Akt enzymatic activity ( Figure 1a ) and level of phosphorylated Akt (Figure 1b) . Additionally, AI-III did not have any effect on PI3 kinase activity (data not shown).
The effect of Akt inhibition using LY and AI-III on cell viability of Jurkat T cells was examined by trypan blue dye exclusion. Both LY and AI-III treatments led to a dramatic decrease in cell viability after 24 h as compared to untreated cells ( Figure 2 ). To determine if the cell death due to inhibition of Akt was by the induction of apoptosis, we measured DNA fragmentation, which is a well-established marker of apoptosis. The effect of Akt inhibition on DNA fragmentation was quantified in cytoplasmic extracts using the Cell Death detection ELISA assay. LY induced concentration-dependent DNA fragmentation within 6 h, with a three-fold increase at 50 mM compared to untreated cells (Figure 3a . These data confirm previous observations that Akt is critical for T lymphocyte survival and that inhibition of Akt leads to apoptotic T-cell death.
29-31

Effect of Akt inhibition on FasL expression
The above data demonstrate that inhibition of Akt induces apoptotic T-cell death. Since FasL is a well-established apoptotic stimulus for T lymphocytes, we examined FasL expression in Akt-inhibited Jurkat T cells. Taken together, these data demonstrate that inhibition of Akt leads to the upregulation of FasL expression, DISC formation and accompanying loss of c-FLIP s resulting in caspase-8-dependent apoptotic death.
Effect of Akt inhibition on Bid truncation, mitochondrial transmembrane potential (DW m ) and caspase-3 maturation
Fas mediated caspase-8 activation can initiate the mitochondrial apoptotic pathway by cleaving Bid, a proapoptotic member of the Bcl-2 family. 20, 21 After activation, the truncated Bid (t-Bid) translocates to the mitochondrial membrane and causes a decrease in the mitochondrial transmembrane potential (DC m ) initiating mitochondrial apoptotic signaling, leading ultimately to the activation of the effector caspases (e.g. caspase-3). Hence, to evaluate the involvement of the mitochondrial pathway in the Fas-mediated apoptotic death induced in Akt kinase-inhibited cells, Bid cleavage, decrease in DC m , and maturation of caspase-3 were examined.
In correspondence with caspase-8 activation, treatment of cells with AI-III induced significant Bid cleavage (t-Bid formation) as compared to the untreated cells (Figure 7a (Figure 6d ). These data suggest that caspase-8 activation triggered by Akt kinase inhibition is not secondary to the mitochondrial amplification loop, and is critical for initiating mitochondrial depolarization leading to apoptotic death.
The effect of the above events on the activation of the effector caspase-3 was further determined. In correspondence 
Discussion
Apoptotic death induced in activated thymocytes or previously stimulated mature T cells plays a critical role in the normal functioning of the immune system. 25 FasL expression plays a major role in the AICD of activated mature T cells and T cell hybridomas. 32 The crucial role of FasL in the regulation of immune homeostasis strongly indicates that its expression must be tightly regulated. Identification of the pathways regulating FasL expression is highly relevant in order to understand the function and survival of T lymphocytes and consequently the immune response. In one group, NOK-2 antibody (50 mg/ml) or the isotype IgG 2a (50 mg/ml) control was added 1 h after treating the cells with LY or AI-III, and then the cells were harvested after 6 h to measure apoptosis. Cytoplasmic extracts were prepared and analyzed for DNA fragmentation using the Cell Death ELISA kit. Data are normalized to the untreated control and represented as mean7S.E.M. of three different experiments. **Po0.01, ***Po0.001 compared to LY or AI-III, respectively
Akt is involved in the lymphokine and co-stimulatory molecule activated survival pathways that inhibit Fasmediated apoptosis. 30, 33 Recent work in vascular smooth muscle cells has shown that Akt kinase regulates FasL expression, 34 and our work shows that Akt inhibition leads to the upregulation of FasL expression and DNA fragmentation in HeLa cells (data not shown). Hence, although Akt kinase is implicated in other cell systems, its role in the regulation of FasL expression and subsequent apoptotic pathway has not been examined in T lymphocytes. In the present work, we examined the role of Akt in the regulation of FasL expression, Fas-mediated apoptotic signaling and cell survival in Jurkat T lymphocytes that have been extensively used as a model system to detail molecular mechanisms involved in T cell activation, function and death. 35 Additionally, the effect of Akt inhibition was also examined in a different human T cell line -MOLT 4.
Inhibition of Akt by both a PI3 kinase inhibitor as well as a selective Akt inhibitor led to an upregulation in FasL mRNA and protein. The upregulation in FasL mRNA expression could be due to the effect of Akt-mediated phosphorylation affecting transcription factors like FKHRL1, which have been proposed to regulate FasL gene promoter activity. 29 Studies to investigate the mechanisms of FasL upregulation in Aktinhibited T lymphocytes are currently underway. In contrast to our findings, data obtained from T cells treated with glucocorticoids indicate that Akt kinase under the influence of Ft1 via GSK3 and NF-AT c signaling induces the production of FasL and causes apoptotic death. 36 These findings indicate that Akt kinase plays a differential role in regulating FasL expression and apoptotic signaling and is dependent on the cellular context and the type of stimulus and signaling components involved.
Apoptosis induced by Akt inhibition was significantly blocked by incubation with FasL neutralizing antibody, demonstrating the functional relevance of FasL expression under these (Akt inhibited) conditions. Although neutralization of FasL significantly protected Jurkat cells from undergoing apoptosis, the NOK-2 antibody did not completely abrogate DNA fragmentation, suggesting the possible involvement of both Fas-dependent and Fas-independent pathways leading to T cell death.
Early events in the FasL-initiated signaling pathway have been well characterized. Triggering of Fas by FasL leads to its trimerization followed by recruitment of the adaptor molecule FADD, and procaspase 8, forming DISC (reviewed in Peter and Krammer 17 ). Our data show that Akt kinase inhibition induces FasL expression leading to Fas-FasL-dependent clustering of Fas and formation of DISC involving recruitment of FADD and procaspase-8. Also, the presence of cleaved caspase-8 together with FADD and procaspase-8 in the DISC assembly shows that caspase-8 is activated at the DISC. Moreover, AI-III treatment enhanced the recruitment of FADD and procaspase-8 in a dose-dependent manner, suggesting that the enhancement in the DISC formation is correspondent to the extent of Akt inhibition occurring in T lymphocytes.
Apoptosis of activated T cells mediated by Fas is known to be regulated by c-FLIP expression. There are two isoforms of c-FLIP, c-FLIP s and c-FLIP L , both of which can be recruited to the DISC. 17 Although the role of c-FLIP L is controversial, in T cells c-FLIP s is demonstrated to be antiapoptotic and confers resistance to Fas-mediated apoptosis by blocking proteolytic activation of caspase-8 at the DISC. 17, 18 Regulation of c-FLIP expression in T lymphocytes is not completely understood. In cells stimulated with the T cell mitogen concanavalin A (conA), MAP kinase kinase (MKK-1) is implicated in the induction of c-FLIP expression. 37 Studies using PI3 kinase inhibitors have implicated the PI3 kinase pathway as an important regulator of c-FLIP expression in nonlymphoid tumor cells; 38, 39 however, the specific role of Akt in regulating c-FLIP expression in T lymphocytes has not been elucidated. Our study shows that inhibition of Akt downregulates c-FLIP s expression, and specifically implicates Akt as the key regulator of c-FLIP s and Fas-mediated apoptosis in T cells . Similar to our observations in T lymphocytes, other studies have also found a link between Akt inhibition and consequent c-FLIP downregulation in different cell types. [40] [41] [42] It is possible that, in addition to suppressing Akt, the Akt inhibitors used in this study may affect Fas-mediated apoptosis through modulation of other relevant signaling molecules besides c-FLIP. Additionally, it should be noted that the requirement of Akt kinase to support c-FLIP s expression may differ depending on the cell type and its activation state. Recently, Kuenzi et al 43 reported that the PI3K inhibitor LY did not downregulate c-FLIP expression in T cells of bovine origin transformed by Theileria parva parasite infection. These results indicate that Akt kinase can regulate Fas-mediated apoptotic signaling in a differential and cell/signaling context-dependent manner.
In AI-III-treated cells, the resultant increase in FasL expression, DISC assembly and caspase-8 activation was accompanied by Bid cleavage, decrease in DC m and activation of the executioner caspase-3. These data suggest that the Fas-mediated apoptotic pathway induced by Akt inhibition via FasL expression is linked to the mitochondrial pathway. Consistent with this notion, we found that caspase-8 inhibitor treatment significantly blocked the decrease in DC m and downstream DNA fragmentation caused by Akt inhibition. Additionally, activation of caspase-8 at the DISC and the ability of caspase-8 inhibitor to prevent the loss of DC m as well as DNA fragmentation strongly suggest that caspase-8 activation triggered by Akt inhibition is not secondary to the mitochondrial amplification loop. Importantly, these data also suggest that in T lymphocytes, formation of DISC leading to increased caspase-8 activation is the critical initiator of apoptotic death induced in response to Akt inhibition.
Overall, our study indicates that, in addition to other known antiapoptotic functions, Akt regulates Fas-mediated as well as mitochondrial apoptotic pathways in T lymphocytes and hence plays a critical role in physiological as well as pathophysiological conditions that involve Fas-mediated apoptosis of T lymphocytes.
Materials and Methods
Cell culture
Jurkat T cells (clone E6-1, ATCC, Rockville, MD, USA) and MOLT-4 T cells (ATCC, Rockville, MD, USA) were grown in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 10 U/ml of penicillin, 10 mg/ml streptomycin (Invitrogen Corporation, Grand Island, NY, USA), in a 371C and 5% CO 2 environment. Jurkat cells were resuspended at 1 Â 10 6 cells/ ml during treatment.
Reagents and antibodies
Akt-specific inhibitor (Akt inhibitor III -(AI-III)) was purchased from Calbiochem (La Jolla, CA, USA), PI3/Akt inhibitor LY-294002 was purchased from Biomol (Plymouth Meeting, PA, USA). Anti-human FasL NOK-2 antibody and the isotype IgG 2a were purchased from BD Biosciences Pharmigen (San Diego, CA, USA). PHA was purchased from Sigma (St Louis, MO, USA). Caspase-8 inhibitor II was purchased from Calbiochem (La Jolla, CA, USA). 
Akt activity assay
Akt activity was measured by one of two methods: (a) enzymatic assay or (b) ELISA assay. For the enzymatic assay, treated Jurkat cells were collected after 6 h and lysed in lysis buffer (PBS pH 7.4, 1% NP-40, 200 mM sodium orthovanadate, 0.1 mg/ml phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml aprotinin, 10 mg/ml leupeptin, 4 mg/ml benzamidine, 50 mM potassium fluoride, 1 mM b-glycerophosphate, 5 mM sodium pyrophosphate, 1 mM okadaic acid) and centrifuged at 15 000 Â g for 10 min at 41C. Akt protein was immunoprecipitated from total cell extracts. Purified Akt substrate was added and the kinase reaction was started by adding 10 mCi [ 32 P]ATP diluted with 0.5 mM cold ATP and samples were incubated for 15 min at 371C. After centrifugation, equal aliquots of the supernatants were transferred to Pierce Phosphocellulose Unit, washed three times with binding buffer. The radioactivity bound to the membrane was then counted as a measure of Akt activity. Additionally, we examined Akt phosphorylation to evaluate Akt activity. Total cell lysates were prepared from treated Jurkat cells (after 6 h treatment) and Akt phosphorylation was measured using an ELISA Kit (Biosource International, Camarillo, CA, USA) according to the manufacturer's procedures.
Trypan blue dye exclusion
To measure viability, cells were stained with trypan blue dye and then counted by a method described elsewhere. 44 
DNA fragmentation ELISA assay
Treated Jurkat cells or MOLT-4 cells were lysed after 6 h to measure apoptosis. DNA fragmentation was quantitated using the Cell Death ELISA kit (Roche, Indianapolis, IN, USA). The assay is based on quantitative sandwich-enzyme-immunoassay principle using mouse monoclonal antibodies directed against DNA and histones. This allows for the determination of mono-and oligonucleosomes present in the cytoplasmic fraction of cell lysates. The sample was placed into a streptavidin-coated microtiter plate. A mixture of antihistone-biotin-labeled antibody and anti-DNA peroxidase-conjugated antibody was added and incubated for 2 h. After removal of the antibodies by a washing step, the amount of nucleosome-bound fragmented DNA was quantified by the peroxidase retained in the immunocomplex using ABTS (9, 2, 2 0 -Azino-di [3-ethylbenzthiazolin-sulfonate]) as a substrate.
Immunoprecipitation and Western blot analysis
For immunoprecipitation (IP) of the CD95 DISC, 25 Â 10 6 Jurkat T cells were untreated or treated with AI-III 10 or 25 mM for 3 h. Following treatment, cells were lysed with IP lysis buffer (25 mM Tris/HCl, pH 7.6, 150 mM NaCl, 5 mM EDTA, 1 mM Na 3 VO 4 , 50 mM b-glycerophosphate, 10 mM NaF, 1% Triton X-100, 0.5 mM phenylmethylsulfonylfluoride and 1 mg/ml of leupeptin, pepstatin and leucine thiol), and the lysate (300mg of protein/per sample) was incubated with 0.4 mg of anti-FAS (B-10) antibody from Santa Cruz Biotechnology (Santa Cruz, CA, USA) overnight rotation at 41C. The following day, 20 ml of protein A/G Plus agarose from Santa Cruz Biotechnology (Santa Cruz, CA, USA), was added for 2 h rotation at 41C, and then immunoprecipitates were washed four times with IP lysis buffer, then separated on a 10% SDS-PAGE and subjected to standard immunoblotting procedures. The polyvinylidene difluoride membrane was immunoblotted with an anti-FADD antibody and with an anti-caspase-8 antibody.
For Western blot analysis, following treatment, cells were lysed and total cellular proteins (60 mg of protein) were resolved on 12% SDS-PAGE and subjected to standard immunoblotting procedures. The primary antibodies used were Fas-L (C-178), anti-FLIPg/d, anti-caspase-3, antiBid and b-actin. The appropriate secondary antibodies were used at 1 : 5000 for all the antibodies. Protein signals were visualized using the ECL system (Amersham Pharmacia Biotech, Piscataway, NJ, USA), as directed by the manufacturer. The molecular sizes of the developed proteins were estimated by comparison with prestained protein markers (Invitrogen, Carlsbad, CA, USA).
RNA isolation, RT-PCR and real-time PCR analysis
RT-PCR assays were used to assess FasL mRNA levels in Jurkat cells. Total RNA was isolated from treated cells after 3 and 6 h, using TRIZOL (Invitrogen, Carlsbad, CA, USA). For real-time PCR, the first-strand cDNA was synthesized using TaqMan Reverse transcription reagents (Applied Biosystems). The reverse transcription was carried out using 1 Â Taqman RT buffer, 5.5 mM MgCl 2 , 500 mM of each dNTP, 2.5 mM random hexamer, 8 U of RNase inhibitor and 25 U of Multiscribe Reverse Transcriptase with 200 ng of total RNA. The RT conditions were 10 min at 251C, 30 min at 481C and 5 min at 951C. Reactions in which the enzyme or RNA were omitted were used as negative controls. Real-time PCR was performed with an ABI prism 7000 sequence detection system and SYBR green I dye reagents. The specific primers were designed for human GAPDH and Fas ligand using Primer3 software program. The following primers were used in real-time PCR:
hGAPDH-RT-FP: The parameter Ct (threshold cycle) was defined as the fraction cycle number at which the fluorescence passed the threshold. The relative gene expression of FasL was analyzed using 2
ÀDDCt method 45 by normalizing with GAPDH gene expression in all the experiments.
For regular PCR, RNA concentration was determined spectrophotometrically and 1 mg of total RNA was used for RT. Reverse transcription was performed using a commercially available cDNA Cycle kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Subsequently, 5 ml of cDNA products were amplified in 50 ml of 50 mM KCl, 10 mM Tris-HCl, 2.5 mM MgCl 2 
Caspase activity assay
To measure caspase-8 activity, cytoplasmic extracts were prepared from Jurkat cells treated for 8 h, and analyzed using the CASPASE-8 Colorimetric Activity Assay kit (Chemicon International, Temecula, CA, USA) as directed by the manufacturer.
FasL neutralization assay
FasL-dependent cell death was evaluated by a neutralization assay. Briefly, Jurkat cells were treated with LY or AI-III, and 1 h after treatment the NOK-2 antibody or the isotype control was added to the cells and then harvested after 6 h for DNA fragmentation measurement using the Cell Death ELISA kit (Roche, Indianapolis, IN, USA).
Statistical analysis
All data are expressed as mean7S.E.M. The method of analysis used was unpaired analysis of variance with the Tukey-Kramer multiplecomparison test. Differences were considered statistically significant for Po0.05.
